Field dossier · from the corpus
In vivo
0predicted collisions
Where this field is predicted to collide
No open collisions on this field in the current run.
Most cited work
Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Epithelial Mesenchymal Transition in Tumor Metastasis
Organoids as an in vitro model of human development and disease
Recent work · 2024 onward
Exagamglogene Autotemcel for Severe Sickle Cell Disease
Advances in HIV Gene Therapy
Therapeutic in vivo genome editing: innovations and challenges in rAAV vector-based CRISPR delivery
Challenges and Opportunities in Lentivirus Viral Vector Manufacturing for In Vivo Applications
Anticodon-edited transfer RNAs (ACE-tRNAs) encoded as therapeutic nonviral minimal DNA vectors
Hematopoietic stem cell therapy with gene modification to treat sickle cell disease